Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon vs Sevoflurane and TIVA for CABG Surgery
NCT01294163Phase 3Completed
- Sponsor
- Air Liquide
- Start
- Apr 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of xenon in coronary artery disease (CAD), sponsored by Air Liquide. Started Apr 2011; status: completed.
02
Drugs
xenon
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01294163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01294163.